Xcell Biosciences Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.4M

  • Investors
  • 20

Xcell Biosciences General Information

Description

Developer of a bench-top primary cell control system designed to advance immunotherapy research and manufacturing, empowering scientists with better tools for cell maintenance, expansion, and control. The company's technology supports a range of primary cell types, including immune, stem, and tumor cells, enabling clients with predictive therapy development and improved clinical outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 455 Mission Bay Boulevard South
  • San Francisco, CA 94158
  • United States
+1 (510)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 455 Mission Bay Boulevard South
  • San Francisco, CA 94158
  • United States
+1 (510)

Xcell Biosciences Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xcell Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 17-Dec-2024 $1.4M Completed Generating Revenue
6. Later Stage VC (Series B) 14-Jun-2024 Completed Generating Revenue
5. Later Stage VC (Series B) 13-Sep-2021 Completed Generating Revenue
4. Later Stage VC (Series A) 23-Feb-2017 Completed Generating Revenue
3. Seed Round 01-May-2015 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view Xcell Biosciences’s complete valuation and funding history, request access »

Xcell Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Xcell Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Xcell Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a bench-top primary cell control system designed to advance immunotherapy research and manufacturing, empow
Discovery Tools (Healthcare)
San Francisco, CA
29 As of 2024

Cambridge, United Kingdom
 

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Xcell Biosciences Competitors (8)

One of Xcell Biosciences’s 8 competitors is Sphere Fluidics, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sphere Fluidics Venture Capital-Backed Cambridge, United Kingdom
Oxford Nanopore Technologies Formerly VC-backed Oxford, United Kingdom
Cytena Formerly VC-backed Freiburg, Germany
HiFiBiO Therapeutics Venture Capital-Backed Cambridge, MA
Pacific Biosciences Formerly VC-backed Menlo Park, CA
You’re viewing 5 of 8 competitors. Get the full list »

Xcell Biosciences Patents

Xcell Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240002774-A1 Multiple incubator cell culture system with atmospheric regulation operated by an integrated control system Pending 04-Aug-2020
GB-202213128-D0 Gas and liquid flow regulation system for cell culture Pending 14-Feb-2020
GB-2608310-A Gas and liquid flow regulation system for cell culture Pending 14-Feb-2020
US-20230212500-A1 Gas and liquid flow regulation system for cell culture Pending 14-Feb-2020
EP-4103201-A1 Gas and liquid flow regulation system for cell culture Pending 14-Feb-2020 C12M41/40
To view Xcell Biosciences’s complete patent history, request access »

Xcell Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xcell Biosciences Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Avego Management PE/Buyout Minority
Berkeley SkyDeck Accelerator/Incubator Minority
Casdin Capital Venture Capital Minority
Dynamk Capital Venture Capital Minority
Formic Ventures Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

Xcell Biosciences FAQs

  • When was Xcell Biosciences founded?

    Xcell Biosciences was founded in 2012.

  • Where is Xcell Biosciences headquartered?

    Xcell Biosciences is headquartered in San Francisco, CA.

  • What is the size of Xcell Biosciences?

    Xcell Biosciences has 29 total employees.

  • What industry is Xcell Biosciences in?

    Xcell Biosciences’s primary industry is Discovery Tools (Healthcare).

  • Is Xcell Biosciences a private or public company?

    Xcell Biosciences is a Private company.

  • What is Xcell Biosciences’s current revenue?

    The current revenue for Xcell Biosciences is .

  • How much funding has Xcell Biosciences raised over time?

    Xcell Biosciences has raised $61.8M.

  • Who are Xcell Biosciences’s investors?

    Avego Management, Berkeley SkyDeck, Casdin Capital, Dynamk Capital, and Formic Ventures are 5 of 20 investors who have invested in Xcell Biosciences.

  • Who are Xcell Biosciences’s competitors?

    Sphere Fluidics, Oxford Nanopore Technologies, Cytena, HiFiBiO Therapeutics, and Pacific Biosciences are some of the 8 competitors of Xcell Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »